Report cover image

Mexico Ultrapure Water Treatment Systems Market

Publisher Grand View Research
Published Jan 12, 2026
Length 100 Pages
SKU # GV20873156

Description

Mexico Ultrapure Water Treatment Systems Market Summary

The Mexico ultrapure water treatment systems market size was estimated at USD 270.2 million in 2025 and is projected to reach USD 418.2 million by 2033, growing at a CAGR of 5.8% from 2026 to 2033. The market growth is driven by the rapid growth in semiconductor, pharmaceutical, and biotechnology manufacturing, where extremely high water purity is essential for process reliability and product quality.

The expansion of advanced manufacturing facilities, supported by nearshoring and foreign direct investment, is increasing the demand for ultrapure water in cleaning, rinsing, formulation, and sterilization processes. Another key driving factor for the Mexico ultrapure water treatment systems industry is the tightening regulatory and sustainability landscape in Mexico. Industries are required to meet higher environmental compliance standards while also improving water-use efficiency in water-stressed regions. This is pushing end users to adopt advanced ultrapure water systems with higher recovery rates, recycling capabilities, and real-time monitoring. At the same time, rising focus on lifecycle cost optimization and operational reliability is encouraging upgrades from conventional systems to more efficient ultrapure water treatment technologies.

Mexico Ultrapure Water Treatment Systems Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Mexico ultrapure water treatment systems market report based on technology,application, and end use:
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Reverse Osmosis
  • Ion Exchange
  • Ultrafiltration
  • Electrodeionization
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cleaning
  • Etching
  • Ingredient
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Semiconductor
  • Pharmaceuticals
  • Power Generation
  • Food & Beverage
  • Healthcare
  • Others
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

100 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Treatment
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising burden of hemorrhagic stroke
3.2.1.2. Growing focus on minimally invasive procedures
3.2.1.3. Technological advancements in neurovascular devices
3.2.2. Market Restraints Analysis
3.2.2.1. High cost of devices and procedures
3.2.2.2. Product recalls
3.2.3. Market Opportunity Analysis
3.2.3.1. Growing emphasis on R&D expansion
3.2.3.2. Rising public awareness about hemorrhagic stroke
3.2.3.3. Increasing clinical trials
3.2.3.4. Increasing launches of devices for ischemic stroke treatment
3.2.3.5. Expansion opportunities in emerging markets
3.2.3.6. Rising stroke incidence among younger adults
3.2.4. Market Challenge Analysis
3.2.4.1. Complications associated with neurovascular treatments
3.2.4.2. Limited skilled professionals
3.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Treatment Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market: Treatment Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Size & Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
4.4. Aneurysm & Hemorrhagic Stroke Interventions
4.4.1. Aneurysm & hemorrhagic stroke interventions market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2. By indication
4.4.2.1. By indication market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2.2. Intracranial aneurysm
4.4.2.2.1. Intracranial aneurysm market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2.3. cSDH (MMA Embolization)
4.4.2.3.1. cSDH (MMA Embolization) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2.4. AVM & AVF embolization
4.4.2.4.1. AVM & AVF embolization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3. By device
4.4.3.1. By device market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3.2. Embolization coiling systems
4.4.3.1.1. Embolization coiling systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3.2. Flow diversion systems
4.4.3.2.1. Flow diversion systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3.3. Intrasaccular flow disruption devices
4.4.2.3.1. Intrasaccular flow disruption devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3.4. Liquid embolization agents
4.4.3.4.1. Liquid embolization agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Ischemic Stroke Interventions (Mechanical Revascularization)
4.5.1. Ischemic stroke interventions (Mechanical Revascularization) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2. Stent retriever systems
4.5.2.1. Stent retriever systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3. Aspiration-based thrombectomy systems
4.5.3.1. Aspiration-based thrombectomy systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6. Cerebral Angioplasty & Vascular Remodeling
4.6.1. Cerebral angioplasty & vascular remodeling market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6.2. Balloon angioplasty systems
4.6.2.1. Balloon angioplasty systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6.3. Intracranial & carotid stenting systems
4.6.3.1. Intracranial & carotid stenting systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6.4. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted)
4.6.4.1. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.7. Ancillary & procedural access devices
4.7.1. Ancillary & procedural access devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.7.2. Guiding & distal access catheters
4.7.2.1. Guiding & distal access catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.7.3. Microcatheters
4.7.3.1. Microcatheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.7.4. Access sheaths & wires
4.7.4.1. Access sheaths & wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Hemorrhagic & Ischemic Stroke Treatment Devices Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market: End use Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Specialty Neurosurgery Centers
5.5.1. Specialty neurosurgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Ambulatory Surgical Centers
5.6.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Regional Estimates & Trend Analysis by Treatment, and End Use
6.1. Regional Dashboard
6.2. Market Size and Trend Analysis, 2021 to 2033
6.3. North America
6.3.1. North America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Competitive scenario
6.3.2.3. Regulatory framework
6.3.2.4. Reimbursement scenario
6.3.2.5. U.S. hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Competitive scenario
6.3.3.3. Regulatory framework
6.3.3.4. Reimbursement scenario
6.3.3.5. Canada hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Competitive scenario
6.3.4.3. Regulatory framework
6.3.4.4. Reimbursement scenario
6.3.4.5. Mexico hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.4. Europe
6.4.1. Europe hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Competitive scenario
6.4.2.3. Regulatory framework
6.4.2.4. Reimbursement scenario
6.4.2.5. UK hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Competitive scenario
6.4.3.3. Regulatory framework
6.4.3.4. Reimbursement scenario
6.4.3.5. Germany hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Competitive scenario
6.4.4.3. Regulatory framework
6.4.4.4. Reimbursement scenario
6.4.4.5. France hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Competitive scenario
6.4.5.3. Regulatory framework
6.4.5.4. Reimbursement scenario
6.4.5.5. Italy hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Competitive scenario
6.4.6.3. Regulatory framework
6.4.6.4. Reimbursement scenario
6.4.6.5. Spain hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Competitive scenario
6.4.7.3. Regulatory framework
6.4.7.4. Reimbursement scenario
6.4.7.5. Sweden hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Competitive scenario
6.4.8.3. Regulatory framework
6.4.8.4. Reimbursement scenario
6.4.8.5. Denmark hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key country dynamics
6.4.9.2. Competitive scenario
6.4.9.3. Regulatory framework
6.4.9.4. Reimbursement scenario
6.4.9.5. Norway hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework
6.5.2.4. Reimbursement scenario
6.5.2.5. China hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Japan hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Competitive scenario
6.5.4.3. Regulatory framework
6.5.4.4. Reimbursement scenario
6.5.4.5. India hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Competitive scenario
6.5.5.3. Regulatory framework
6.5.5.4. Reimbursement scenario
6.5.5.5. South Korea hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.5.6. Australia
6.5.6.1. Key country dynamics
6.5.6.2. Competitive scenario
6.5.6.3. Regulatory framework
6.5.6.4. Reimbursement scenario
6.5.6.5. Australia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.5.7. Thailand
6.5.7.1. Key country dynamics
6.5.7.2. Competitive scenario
6.5.7.3. Regulatory framework
6.5.7.4. Reimbursement scenario
6.5.7.5. Thailand hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Latin America
6.6.1. Latin America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Brazil hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Argentina hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Middle East and Africa
6.7.1. Middle East and Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. South Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Saudi Arabia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. UAE hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Kuwait hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Market Share Analysis, 2025
7.4. Company Heat Map Analysis
7.5. Strategy Mapping
7.5.1. Expansion
7.5.2. Mergers & Acquisition
7.5.3. Partnerships & Collaborations
7.5.4. New Treatment Launches
7.5.5. Research And Development
7.5.6. Company Profiles
7.5.7. Medtronic
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Treatment Benchmarking
7.5.7.4. Strategic initiatives
7.5.8. MicroVention, Inc. (Terumo Corporation)
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Treatment Benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Balt
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Treatment Benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Scientia Vascular, Inc.
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Treatment Benchmarking
7.5.10.4. Strategic initiatives
7.5.11. MicroPort Scientific Corporation
7.5.11.1. Company overview
7.5.11.2. Financial performance
7.5.11.3. Treatment Benchmarking
7.5.11.4. Strategic initiatives
7.5.12. Johnson & Johnson (MedTech)
7.5.12.1. Company overview
7.5.12.2. Financial performance
7.5.12.3. Treatment Benchmarking
7.5.12.4. Strategic initiatives
7.5.13. phenox GmbH (Wallaby Medical)
7.5.13.1. Company overview
7.5.13.2. Financial performance
7.5.13.3. Treatment Benchmarking
7.5.13.4. Strategic initiatives
7.5.14. Acandis GmbH
7.5.14.1. Company overview
7.5.14.2. Financial performance
7.5.14.3. Treatment Benchmarking
7.5.14.4. Strategic initiatives
7.5.15. B. Braun SE
7.5.15.1. Company overview
7.5.15.2. Financial performance
7.5.15.3. Treatment Benchmarking
7.5.15.4. Strategic initiatives
7.5.16. Integra LifeSciences
7.5.16.1. Company overview
7.5.16.2. Financial performance
7.5.16.3. Treatment Benchmarking
7.5.16.4. Strategic initiatives
7.5.17. Infinity Neuro LLC
7.5.17.1. Company overview
7.5.17.2. Financial performance
7.5.17.3. Treatment Benchmarking
7.5.17.4. Strategic initiatives
7.5.18. Penumbra, Inc.
7.5.18.1. Company overview
7.5.18.2. Financial performance
7.5.18.3. Treatment Benchmarking
7.5.18.4. Strategic initiatives
7.5.19. Boston Scientific Corporation
7.5.19.1. Company overview
7.5.19.2. Financial performance
7.5.19.3. Treatment Benchmarking
7.5.19.4. Strategic initiatives
7.5.20. Stryker
7.5.20.1. Company overview
7.5.20.2. Financial performance
7.5.20.3. Treatment Benchmarking
7.5.20.4. Strategic initiatives
7.5.21. Peter LAZIC GmbH
7.5.21.1. Company overview
7.5.21.2. Financial performance
7.5.21.3. Treatment Benchmarking
7.5.21.4. Strategic initiatives
7.5.22. Vesalio Inc.
7.5.22.1. Company overview
7.5.22.2. Financial performance
7.5.22.3. Treatment Benchmarking
7.5.22.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us